| Literature DB >> 31309075 |
Afsaneh Qadiri1,2, Fariba Mirzaei Bavil3, GholamReza Hamidian4, Zohreh Zavvari Oskuye1, Mahdi Ahmadi5, Hajar Oghbaei1, Keivan Mehri1, Amir Mansour Vatankhah3, Rana Keyhanmanesh3.
Abstract
OBJECTIVE: The glucose-reducing effects of troxerutin was previously proven. This study was conducted to evaluate troxerutin effect on testicular structure and spermatozoid parameters in type-1 diabetic adult male rats.Entities:
Keywords: Apoposis; Diabetes; Rat; Stress oxidative; Testis; Troxerutin
Year: 2019 PMID: 31309075 PMCID: PMC6612250
Source DB: PubMed Journal: Avicenna J Phytomed ISSN: 2228-7930
Figure 1(a) Blood glucose level (mg/dl) and (b) blood insulin level (µIU/ml) levels in control group (C), healthy animals received troxerutin (T), diabetic animals (DM), diabetic animals that received troxerutin (DT) and diabetic animals that received insulin (DI) (n=6 in each group). + p<0.05 and +++ p<0.001 show statistical differences between control and different groups. * p<0.05 and *** p<0.001 show statistical differences between troxerutin and different groups. iii p<0.001 show statistical differences between between DT and DI with DM group. ### p<0.001 shows statistical differences between DI and DT group
Figure 2Testicular (a) GPX activity (mU/mg protein), (b) MDA content (pmol/mg), and (c) SOD activity (mU/mg protein) in the testes of control group (C), healthy animals received troxerutin (T), diabetic animals (DM), diabetic animals received troxerutin (DT) and diabetic animals received insulin (DI) (f n=6 in each group). + p<0.05, ++ p<0.01 and +++ p<0.001 show statistical differences between control and different groups. ** p<0.01 and *** p<0.001 show statistical differences between troxerutin and different groups. i p<0.05 shows statistical differences between DT and DI with DM group. GPX, Glutathione peroxidase; MDA, Malondialdehyde; SOD, Superoxide dismutase
Figure 3Photomicrographs of apoptotic cells in the testis of (A) control, (B) healthy animals that received troxerutin, (C) diabetic animals, (D) diabetic animals that received troxerutin and (E) diabetic animals that received insulin. Brown-yellow dots display the positive (apoptotic) cells. (Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL); X400)
Testicular morphometric and stereological findings in control group (C), healthy animals that received troxerutin (T), diabetic animals (DM), diabetic animals that received troxerutin (DT) and diabetic animals that received insulin (DI) (n=6 in each group)
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| 1.07±0.10 | 1.27±0.10 | 1.14±0.20 | 1.05±0.10 | 0.91±.05 | Testes relative weight (%) |
| 1.15±0.10 | 0.97±0.10 | 0.95±0.10 | 1.10±0.10 | 0.95±0.5 | Left testicle weight (g) |
| 1.77±0.05 | 1.65±0.10 | 1.55±0.04 | 1.71±0.10 | 1.71±0.04 | Left testicle length (cm) |
| 0.94±0.02 | 0.82±0.04 | 0.79±0.01 | 0.84±0.01 | 0.89±0.04 | Left testicle width (cm) |
| 1.05±0.01 | 0.96±0.02 | 0.95±0.13 | 1.07±0.11 | 0.99±0.02 | Left testicle height (cm) |
| 1200.00±69.20 | 1088.00±51.61 | 982.00±34.40 | 1212.00±36.00 | 1110.00±25.10 | Left testicle volume (mm3) |
| 1006.30±61.00 | 903.36±45.20 | 682.78±19.00 | 1089.67±33.15 | 983.98±28.50 | Seminiferous tubule volume (mm3) |
| 788.62±62.30 | 693.44±42.30 | 356.44±7.92 | 894.92±31.50 | 778.60±37.6 | Germinal epithelium volume (mm3) |
| 217.68±6.35 | 209.92±4.25 | 326.34±14.90 | 194.75±5.60 | 205.38±10.80 | Lumen volume (mm3) |
| 29.38±4.54 | 25.96±2.50 | 45.16±2.80 | 18.25±2.05 | 20.08±1.72 | Capsule volume (mm3) |
| 164.32±6.12 | 158.68±6.84 | 254.06±14.42 | 104.08±3.30 | 105.94±5.80 | Interstitial tissue volume (mm3) |
| 17.46±0.80 | 17.38±0.85 | 14.53±0.60 | 17.64±0.30 | 16.86±0.50 | Seminiferous tubule length (m) |
| 423.00±1.22 | 422.00±1.22 | 407.00±2.00 | 432.00±1.22 | 435.00±3.53 | Seminiferous tubule diameter (µm) |
| 120.00±2.23 | 119.00±1.90 | 111.00±1.00 | 139.00±1.00 | 138.00±1.22 | Germ cell layer height (µm) |
| 36.00±2.07 | 34.70±1.50 | 29.46±1.03 | 59.39±2.82 | 59.86±0.83 | No. of spermatogonia (×106) |
| 170.94±7.41 | 155.34±6.30 | 127.74±6.10 | 217.68±4.25 | 217.40±3.75 | No. of spermatocyte (×106) |
| 279.44±12.60 | 275.20±8.40 | 253.68±11.72 | 376.98±6.84 | 377.34±12.65 | No. of round spermatid (×106) |
| 306.88±16.60 | 274.92±6.50 | 251.80±14.24 | 426.26±10.20 | 430.66±12.60 | No. of elongated spermatid (×106) |
| 24.44±1.34 | 24.62±0.40 | 15.49±0.42 | 31.27±1.20 | 32.00±1.71 | No. of Sertoli cells (×106) |
| 17.46±0.80 | 17.50±0.60 | 11.99±0.64 | 20.61±0.80 | 21.09±0.50 | No. of Leydig cells (×106) |
No; number.
; p<0.01 and
; p<0.001 show statistical differences between control and different groups.
; p<0.05,
; p<0.01,
and p<0.001 show statistical differences between troxerutin and different groups.
p<0.05,
; p<0.01,
;p<0.001 show statistical differences between DT and DI with DM group.